Disclosed is the use of a composition consisting essentially of (as herein defined) lactoferrinand immunoglobulin in the preparation of a medicament for minimizing the severity of one or more symptoms associated with eczema, wherein the lactoferrin and immunoglobulin are present in a mass ratio of 1:1.